Toshiyuki Maki
Publications by Year
Research Areas
Heart Failure Treatment and Management, Peptidase Inhibition and Analysis, Pancreatic function and diabetes, Cardiac Fibrosis and Remodeling, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions(2007)1,380 cited
- → Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity(2004)544 cited
- → Peroxisome Proliferator–Activated Receptor (PPAR)α Activation Increases Adiponectin Receptors and Reduces Obesity-Related Inflammation in Adipose Tissue(2005)404 cited
- → Insulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus(2004)235 cited
- → Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts(2003)181 cited
- → Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2(2007)137 cited
- → Nerve and muscle vulnerability to ischemia(1985)58 cited
- → Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts(2000)49 cited
- → Magnetic Resonance Imaging Findings of Machado–Joseph Disease: Histopathologic Correlation(2003)39 cited
- → Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts(2004)36 cited